Clincosm LogoSign in Get a demo

Acute Myelogenous Leukemia

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • FT-2102 (olutasidenib)
    • +2 more
    • Los Angeles, California
    • +59 more
    Mar 2, 2022

    Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Gilbert, Arizona
    • +23 more
    Feb 22, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    Oct 13, 2021

    Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • Birmingham, Alabama
    • +16 more
    Apr 14, 2021

    Acute Myelogenous Leukemia Trial in United States (KIR genotype)

    Completed
    • Acute Myelogenous Leukemia
    • KIR genotype
    • Scottsdale, Arizona
    • +18 more
    Mar 9, 2021

    Acute Myelogenous Leukemia Trial in United States (GRNVAC1)

    Completed
    • Acute Myelogenous Leukemia
    • GRNVAC1
    • Atlanta, Georgia
    • +5 more
    Jul 2, 2019

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Tucson, Arizona
    • +29 more
    Jun 17, 2019

    Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,

    Completed
    • Acute Myeloid Leukemia
    • Acute Myelogenous Leukemia
    • Standard dose cytarabine for induction
    • +3 more
    • Birmingham, Alabama
    • +12 more
    May 8, 2018

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia Trial in United States (HMA, SGN-CD33A)

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Jan 3, 2018

    Refractory Leukemia, Acute Myelogenous Leukemia Trial in Worldwide (Panobinostat/LBH589)

    Completed
    Has Results
    • Refractory Leukemia
    • Acute Myelogenous Leukemia
    • Chicago, Illinois
    • +39 more
    Jan 8, 2017

    Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • clofarabine (IV formulation)
    • +2 more
    • Scottsdale, Arizona
    • +56 more
    Mar 17, 2014

    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • VCL-CB01
    • Phosphate-buffered Saline (PBS)
    • Tucson, Arizona
    • +21 more
    Jul 31, 2013

    Acute Myelogenous Leukemia, MDS, Chronic Myelogenous Leukemia Trial in Dallas (Clofarabine and Cytarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +2 more
    • Clofarabine and Cytarabine
    • Dallas, Texas
      Baylor University Medical Center
    Jul 15, 2013